
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+2
HysensBio is developing a first-in-class therapeutics for the most common dental disease in the world. With over 20 years of fundamental dental research HysensBio has developed the worlds first technology to regenerate physiologic dentin and periodontal ligament. Through this, we are opening a new area in the treatment of dental diseases, such as dentin hypersensitivity, dental caries and periodontal disease
Bio tech,dental disease treatment,first-in-class drug,dental hypersenstivity,dental caries,periodontal ligament disease,and animal dental drug
Hysensbio operates in the Biotechnology research industry.
Hysensbio's revenue is 11m - 100m
Hysensbio has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.